DS-1 (drug)

Source: Wikipedia, the free encyclopedia.
DS-1
Identifiers
  • 4-chloro-N-(6,8-dibromo-2-thiophen-2-ylimidazo[1,2-a]pyridin-3-yl)benzamide
JSmol)
  • s4cccc4-c2nc1c(Br)cc(Br)cn1c2NC(=O)c(cc3)ccc3Cl
  (verify)

DS-1 is a drug from the

positive allosteric modulator (PAM) selective for the α4β3δ subtype, which is not targeted by other GABAA receptor PAMs such as the benzodiazepines or other nonbenzodiazepine drugs. Novel selective drugs such as DS-1 are useful in the study of this receptor subtype.[1][2][3]

See also

References

  1. S2CID 207224202
    .
  2. PMID 29451785
    .
  3. S2CID 89619321
    .
Stub icon

This sedative-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=DS-1_(drug)&oldid=1207050485"